Showing results (31-40 of 1,786) with videos related to

Sort By:
Pageof 179
Hepatology Communications|September 12, 2018
Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis CWataru Ando, Hiroaki Yokomori, Fumihiko Kaneko, et al.
Hepatology Communications|February 16, 2019
Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the IntestineMichael Pimienta, Alexander Beletsky, Ekihiro Seki
Hepatology Communications|February 16, 2019
Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and ObesityLisa Katharina Maresch, Pia Benedikt, Ursula Feiler, et al.
Hepatology Communications|March 13, 2019
Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million TestsHiam Chemaitelly, Sarwat Mahmud, Silva P Kouyoumjian, et al.
Hepatology Communications|March 13, 2019
IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver FailureKatharina Schwarzkopf, Sabrina Rüschenbaum, Samarpita Barat, et al.
Hepatology Communications|March 13, 2019
Evidence for a Novel Regulatory Interaction Involving Cyclin D1, Lipid Droplets, Lipolysis, and Cell Cycle Progression in HepatocytesHeng Wu, Jonathan M Ploeger, Sushama Kamarajugadda, et al.
Hepatology Communications|February 8, 2021
How Do Patients With Cirrhosis and Their Caregivers Learn About and Manage Their Health? A Review and Qualitative StudyZachary M Saleh, Patricia P Bloom, Katie Grzyb, et al.
Hepatology Communications|February 8, 2021
CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular CarcinomaKyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, et al.
Hepatology Communications|September 10, 2019
Twitter As a Noninvasive Bio-Marker for Trends in Liver DiseaseBen L Da, Pallavi Surana, Samuel A Schueler, et al.
Pageof 179